Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michelle Samuel, MPH"'
Autor:
Lena Rivard, MD, MSc, Michelle Samuel, MPH, PhD, Annik Fortier, MSc, Marie-Claude Guertin, PhD, Paul Khairy, MD, PhD, Denis Roy, MD, Mario Talajic, MD, Jean-Claude Tardif, MD
Publikováno v:
CJC Open, Vol 3, Iss 9, Pp 1100-1107 (2021)
Background: Hypertension is a risk factor for the development and exacerbation of atrial fibrillation (AF). Angiotensin-converting enzyme inhibitors are a standard-of-care treatment option for patients with hypertension; however, there is conflicting
Externí odkaz:
https://doaj.org/article/34a1d6b2aaba4057a9b6961d77f0192c
Autor:
Michelle Samuel, MPH, PhD, Michal Abrahamowicz, PhD, Jacqueline Joza, MD, Vidal Essebag, MD, PhD, Louise Pilote, MD, MPH, PhD
Publikováno v:
CJC Open, Vol 2, Iss 3, Pp 85-93 (2020)
Background: Current guidelines are relatively general regarding the type of patient with heart failure (HF) who should be considered for catheter ablation (CA) of atrial fibrillation (AF). The aim of the present study was to identify clinical predict
Externí odkaz:
https://doaj.org/article/40a4fc7edb8c4365af9f9d579473672b
Autor:
Mohamed Al Rawahi, MD, Michelle Samuel, MPH, Christos Galatas, MD, Jacqueline Joza, MD, Pedro Y. Lima, MD, Rodrigo Barbosa, MD, George Thanassoulis, MD, Martin L. Bernier, MD, Thao Huynh, MD, PhD, Vidal Essebag, MD, PhD
Publikováno v:
CJC Open, Vol 1, Iss 5, Pp 231-237 (2019)
Background: Cerebral thromboembolism is a potentially devastating complication of atrial fibrillation (AF) and atrial flutter (AFl). The use of transesophageal echocardiogram (TEE) before electrophysiological procedures in anticoagulated patients is
Externí odkaz:
https://doaj.org/article/0caabe9bdb6742a797076624e572c98b